Newborn screening bill
This article was originally published in The Gray Sheet
The Newborn Screening Saves Lives Act passes out of the Senate Health, Education, Labor and Pensions Committee Nov. 14. Introduced by Christopher Dodd, D-Conn., S. 1858 was unanimously accepted with a clarifying amendment. It would, among other provisions, authorize $15 million for states to expand their newborn screening programs and seek federal guidelines to test for all 29 disorders recommended for testing by the American College of Medical Genetics. The act would also create a research program to identify and develop new screening technologies
You may also be interested in...
A newborn genetic screening bill signed into law by President Bush April 24, the Newborn Screening Saves Lives Act of 2007, authorizes $15 million in grants for states to expand their newborn screening programs and calls for national guidelines on what conditions should be tested. The act, which was introduced by Sen. Christopher Dodd, D-Conn., also creates a research program to identify and develop new screening technologies ("1The Gray Sheet" Nov. 19, 2007, In Brief)
A Phase III trial testing the antibody-drug conjugate sacituzumab govitecan was stopped early for efficacy, boding well for the BLA pending at the US FDA.
Deal Snapshot: Six companies seek to collect convalescent plasma from COVID-19 survivors to quickly develop hyperimmune immunoglobulin therapy for serious complications of the virus.